Overview
The Dementia Consortium that partners between ARUK and 7 Industry Partners and 2 CROs has accelerated dementia target validation and drug discovery for the development of new treatments.

1 Founding Charity providing access to the best Translational Research into Dementia worldwide
7 Pharmaceutical industry partners
2 Contract-research organisations
Over 80 Scientists currently collaborating across Industry and Academia
Target Applications from 125 academic research organisations across 25 Countries
12 Targets being explored in DC2
8 Targets explored In DC1
A 10m initiative with 6.4m income from Industry

-
1 Founding Charity providing access to the best Translational Research into Dementia worldwide
-
7 Pharmaceutical industry Partners
2 Contract-Research organisations
-
Over 80 Scientists currently collaborating across Industry and Academia
-
Target Applications from 125 Academic research organisations across 25 Countries
-
12 Targets being explored in DC2
8 targets explored in DC1
-
A 10m initiative with 6.5m income from Industry